Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 1/2014

01-01-2014 | Erratum

Erratum to: Differences in metabolic and mitogenic signalling of insulin glargine and AspB10 human insulin in rats

Authors: N. Tennagels, S. Welte, M. Hofmann, P. Brenk, R. Schmidt, U. Werner

Published in: Diabetologia | Issue 1/2014

Login to get access

Excerpt

Erratum to: Diabetologia …
Metadata
Title
Erratum to: Differences in metabolic and mitogenic signalling of insulin glargine and AspB10 human insulin in rats
Authors
N. Tennagels
S. Welte
M. Hofmann
P. Brenk
R. Schmidt
U. Werner
Publication date
01-01-2014
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 1/2014
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-3091-x

Other articles of this Issue 1/2014

Diabetologia 1/2014 Go to the issue

Article

Differential regulation of mouse pancreatic islet insulin secretion and Smad proteins by activin ligands

Article

SMAD2 disruption in mouse pancreatic beta cells leads to islet hyperplasia and impaired insulin secretion due to the attenuation of ATP-sensitive K+ channel activity

Article

Association between alcohol consumption and plasma fetuin-A and its contribution to incident type 2 diabetes in women

Erratum

Erratum to: The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells

Short Communication

Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia

Letter

Risk stratification for diabetic eye screening. Reply to Stratton I. M. and Aldington S. J. [letter]
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits